Virtus LifeSci Biotech Products ETF
17 hedge funds and large institutions have $10.4M invested in Virtus LifeSci Biotech Products ETF in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.22M | |
| 2 | +$606K | |
| 3 | +$85.6K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$60.7K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$49.9K |
Top Sellers
| 1 | -$281K | |
| 2 | -$109K | |
| 3 | -$42.2K | |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$12.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$12K |